Delphi initiative for early-onset colorectal cancer (DIRECt) international management guidelines

dc.contributor.authorCavestro, Giulia Martina
dc.contributor.authorMannucci, Alessandro
dc.contributor.authorBalaguer Prunés, Francesc
dc.contributor.authorHampel, Heather
dc.contributor.authorKupfer, Sonia S.
dc.contributor.authorRepici, Alessandro
dc.contributor.authorSartore-Bianchi, Andrea
dc.contributor.authorSeppälä, Toni T.
dc.contributor.authorValentini, Vincenzo
dc.contributor.authorBoland, Clement Richard
dc.contributor.authorBrand, Randall E.
dc.contributor.authorBuffart, Tineke E.
dc.contributor.authorBurke, Carol A.
dc.contributor.authorCaccialanza, Riccardo
dc.contributor.authorCannizzaro, Renato
dc.contributor.authorCascinu, Stefano
dc.contributor.authorCercek, Andrea
dc.contributor.authorCrosbie, Emma J.
dc.contributor.authorDanese, Silvio
dc.contributor.authorDekker, Evelien
dc.contributor.authorDaca-Alvarez Maria
dc.contributor.authorDeni, Francesco
dc.contributor.authorDominguez Valentin, Mev
dc.contributor.authorEng, Cathy
dc.contributor.authorGoel, Ajay
dc.contributor.authorGuillem, Jose G.
dc.contributor.authorHouwen, Britt B. S. L.
dc.contributor.authorKahi, Charles
dc.contributor.authorKalady, Matthew F.
dc.contributor.authorKastrinos, Fay
dc.contributor.authorKuehn, Florian
dc.contributor.authorLaghi, Luigi
dc.contributor.authorLatchford, Andrew
dc.contributor.authorLiska, David
dc.contributor.authorLynch, Patrick M.
dc.contributor.authorMalesci, Alberto
dc.contributor.authorMauri, Giancarlo
dc.contributor.authorMeldolesi, Elisa
dc.contributor.authorMoller, Pal
dc.contributor.authorMonahan, Kevin
dc.contributor.authorMoeslein, Gabriela
dc.contributor.authorMurphy, Caitlin J.
dc.contributor.authorNass, Karlijn
dc.contributor.authorNg, Kimmie
dc.contributor.authorOliani, Cristina
dc.contributor.authorPapaleo, Enrico
dc.contributor.authorPatel, Swati G.
dc.contributor.authorPuzzono, Marta
dc.contributor.authorRemo, Andrea
dc.contributor.authorRicciardiello, Luigi
dc.contributor.authorRipamonti, Carla Ida
dc.contributor.authorSiena, Salvatore
dc.contributor.authorSingh, Satish K.
dc.contributor.authorStadler, Zsofia K.
dc.contributor.authorStanich, Peter P.
dc.contributor.authorSyngal, Sapna
dc.contributor.authorTuri, Stefano
dc.contributor.authorUrso, Emanuele Damiano
dc.contributor.authorValle, Laura
dc.contributor.authorVanni, Valeria Stella
dc.contributor.authorVilar, Eduardo
dc.contributor.authorVitellaro, Marco
dc.contributor.authorYou, Yi-Qian Nancy
dc.contributor.authorYurgelun, Matthew B.
dc.contributor.authorZuppardo, Raffaella Alessia
dc.contributor.authorStoffel, Elena
dc.date.accessioned2024-02-22T15:09:13Z
dc.date.available2024-02-22T15:09:13Z
dc.date.issued2022-12-20
dc.date.updated2024-02-22T15:09:14Z
dc.description.abstractBackground & aims: Patients with early-onset colorectal cancer (eoCRC) are managed according to guidelines that are not age-specific. A multidisciplinary international group (DIRECt), composed of 69 experts, was convened to develop the first evidence-based consensus recommendations for eoCRC. Methods: After reviewing the published literature, a Delphi methodology was used to draft and respond to clinically relevant questions. Each statement underwent 3 rounds of voting and reached a consensus level of agreement of ≥80%. Results: The DIRECt group produced 31 statements in 7 areas of interest: diagnosis, risk factors, genetics, pathology-oncology, endoscopy, therapy, and supportive care. There was strong consensus that all individuals younger than 50 should undergo CRC risk stratification and prompt symptom assessment. All newly diagnosed eoCRC patients should receive germline genetic testing, ideally before surgery. On the basis of current evidence, endoscopic, surgical, and oncologic treatment of eoCRC should not differ from later-onset CRC, except for individuals with pathogenic or likely pathogenic germline variants. The evidence on chemotherapy is not sufficient to recommend changes to established therapeutic protocols. Fertility preservation and sexual health are important to address in eoCRC survivors. The DIRECt group highlighted areas with knowledge gaps that should be prioritized in future research efforts, including age at first screening for the general population, use of fecal immunochemical tests, chemotherapy, endoscopic therapy, and post-treatment surveillance for eoCRC patients. Conclusions: The DIRECt group produced the first consensus recommendations on eoCRC. All statements should be considered together with the accompanying comments and literature reviews. We highlighted areas where research should be prioritized. These guidelines represent a useful tool for clinicians caring for patients with eoCRC.
dc.format.extent56 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec730041
dc.identifier.issn1542-3565
dc.identifier.pmid36549470
dc.identifier.urihttps://hdl.handle.net/2445/207946
dc.language.isoeng
dc.publisherElsevier
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.cgh.2022.12.006
dc.relation.ispartofClinical Gastroenterology and Hepatology, 2022, vol. 21, num.3, p. 581-637
dc.relation.urihttps://doi.org/10.1016/j.cgh.2022.12.006
dc.rightscc-by-nc-nd (c) AGA Institute, 2023
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationDiagnòstic
dc.subject.classificationCàncer colorectal
dc.subject.classificationAdults
dc.subject.otherDiagnosis
dc.subject.otherColorectal cancer
dc.subject.otherAdulthood
dc.titleDelphi initiative for early-onset colorectal cancer (DIRECt) international management guidelines
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
257049.pdf
Mida:
2.26 MB
Format:
Adobe Portable Document Format